As research on this topic is scarce, it seems reasonable to hypothesize that our finding reflects IgA and IgM pathology (e.g., nephropathy, liver disease) more common among the no-doping than AAS-doping patients in the sample. The gene discussed is CD40LG; the disease is kidney disorder.